Clinical Trials
5
Active:1
Completed:2
Trial Phases
2 Phases
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 4
1 (50.0%)Clinical Study of Active Intervention in High-risk HFpEF Patients
Not Applicable
Not yet recruiting
- Conditions
- Heart Failure With Preserved Ejection Fraction
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Xiangtan Central Hospital
- Target Recruit Count
- 924
- Registration Number
- NCT06532019
Risk Factors In Heart Failure Patients With Preserved Ejection Fraction
Completed
- Conditions
- Heart Failure With Preserved Ejection Fraction
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Xiangtan Central Hospital
- Target Recruit Count
- 9419
- Registration Number
- NCT06487468
Outcome of Discharged HFmrEF Patients
Completed
- Conditions
- Heart Failure With Mid Range Ejection Fraction
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Xiangtan Central Hospital
- Target Recruit Count
- 1693
- Registration Number
- NCT05240118
B-lines-guided Heart Failure Management in Heart Failure Patients
Active, not recruiting
- Conditions
- Lung UltrasoundHeart Failure
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Xiangtan Central Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT05035459
- Locations
- 🇨🇳
Xiangtan Central Hospital, Xiangtan, Hunan, China
Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Xiangtan Central Hospital
- Target Recruit Count
- 1990
- Registration Number
- NCT04707261
- Locations
- 🇨🇳
Xiangtan Central Hospital, Xiangtan, Hunan, China
News
No news found